HUMANIGEN, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.01 EUR | -.--% |
|
-36.71% | -79.47% |
| 05-01 | Combined Hearing for Disclosure Statement and Plan Approved for Humanigen, Inc. | CI |
| 04-12 | Combined Liquidation Plan and Disclosure Statement Filed by Humanigen, Inc. | CI |
Chart calendar Humanigen, Inc.
7f3.QlteLLCfz3Kl-KyDtrpchWBEHi735tDISi-cGX7AEHc.LDAHe8fMl0WXwNnl3ose6AYGVEWOgKWJHm7wIBnxajspOQwe1PW1Csyb9Q~62a1fefe742ff26dd6699811876d4f3e
Upcoming events on Humanigen, Inc.
No events available
Past events on Humanigen, Inc.
| 13/04/2023 | American Association for Cancer Research Meeting |
| 17/11/2022 16:25 | Jefferies London Healthcare Conference |
| 13/11/2022 | Q3 2022 Earnings Release |
| 28/09/2022 14:00 | Cantor Oncology, Hematology & HemeOnc Conference - Panel |
| 12/09/2022 21:00 | H.C. Wainwright Global Investment Conference |
| 12/08/2022 21:00 | Interim 2022 Earnings Release |
| 21/06/2022 14:00 | Lytham Partners Summer Investor Conference |
| 10/06/2022 17:15 | Jefferies Healthcare Conference |
| 09/06/2022 18:00 | Annual General Meeting |
| 07/06/2022 17:00 | LD Micro Invitational XII Conference |
| 24/05/2022 16:00 | H.C. Wainwright Global Life Sciences Investment Conference |
| 11/05/2022 13:20 | LSX World Congress - Panel |
| 10/05/2022 15:45 | LSX World Congress |
| 05/05/2022 21:00 | Q1 2022 Earnings Release |
| 27/03/2022 | BIO Europe Spring Conference |
| 27/03/2022 | MedInvest Pharmaceutical and Biotechnology Investor Conference |
| 16/03/2022 13:20 | Oppenheimer Healthcare Conference |
| 15/03/2022 16:00 | Roth Capital Partners Conference |
| 04/03/2022 14:00 | Oppenheimer March Thought Leadership Series Conference |
| 01/03/2022 08:00 | Credit Suisse London Global Healthcare Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,31 0,00 - | 3,60 2,95 22.05% | 2,51 2,33 7.9% |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -88,2 -93,1 5.22% | -233 -246 5.38% | -68,3 -75,7 9.78% |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -88,2 -92,6 4.76% | -233 -240 3.11% | -68,3 -80,9 15.58% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -89,5 -94,9 5.67% | -237 -245 3.42% | -70,7 -82,5 14.22% |
|
Net income Million USD | Released Forecast Spread | -10,3 | -89,5 -93,8 4.5% | -237 -243 2.48% | -70,7 -82,3 14.06% |
|
EPS USD | Released Forecast Spread | -0,45 | -2,42 -1,80 -34.51% | -4,04 -4,12 1.91% | -0,79 -1,02 22.3% |
| Announcement Date | 16/03/20 | 10/03/21 | 28/02/22 | 30/03/23 |
Quarterly results
| Fiscal Period | December | 2021 Q1 | 2021 Q2 | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,49 0,00 - | 1,04 0,68 51.71% | 1,04 0,07 1453.92% | 1,04 0,42 146.9% | 1,04 0,21 398.08% | 1,04 0,35 198.84% | 0,22 0,35 -36.25% | 0,22 0,10 121% | 0,22 0,00 - |
|
EBITDA Million USD | Released Forecast Spread | -64,4 -31,3 -105.74% | -70,1 -44,3 -58.13% | -66,0 -68,3 3.4% | -32,3 -51,8 37.53% | -20,5 -35,6 42.33% | -29,4 -20,9 -40.44% | -22,7 -20,2 -12.76% | 4,30 -1,88 328.56% | |
|
EBIT Million USD | Released Forecast Spread | -64,4 -34,4 -87.42% | -70,1 -48,4 -44.79% | -66,0 -58,3 -13.12% | -32,3 -39,5 18.19% | -20,5 -28,4 27.71% | -29,4 -22,2 -32.51% | -22,7 -11,2 -102.87% | 4,30 -8,31 151.74% | -4,24 -17,2 75.38% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -65,6 -27,2 -141.23% | -70,8 -42,6 -66.05% | -66,7 -54,2 -23.18% | -33,5 -48,6 31.04% | -21,3 -31,9 33.3% | -30,1 -22,2 -35.91% | -23,7 -16,3 -45.45% | 4,39 -7,57 157.99% | -4,18 -17,2 75.69% |
|
Net income Million USD | Released Forecast Spread | -65,6 -33,6 -95.33% | -70,8 -47,8 -48.23% | -66,7 -56,7 -17.64% | -33,5 -44,4 24.52% | -21,3 -30,0 29.07% | -30,1 -22,4 -34.59% | -23,7 -17,8 -33.11% | 4,39 -13,5 132.52% | -4,18 -17,2 75.69% |
|
EPS USD | Released Forecast Spread | -1,25 -0,64 -95.31% | -1,20 -0,83 -44.1% | -1,12 -0,98 -13.71% | -0,53 -0,65 17.93% | -0,32 -0,46 30.93% | -0,43 -0,32 -34.38% | -0,23 -0,19 -22.67% | 0,16 -0,06 352.64% | -0,04 -0,06 33.33% |
| Announcement Date | 13/05/21 | 12/08/21 | 12/11/21 | 28/02/22 | 05/05/22 | 12/08/22 | 14/11/22 | 30/03/23 | 15/05/23 |
| 11/07/2024 07:00 | BONESUPPORT HOLDING AB: Q2 2024 Earnings Release |
| 15/07/2024 | SWEDISH ORPHAN BIOVITRUM AB: Q2 2024 Earnings Release |
| 22/07/2024 | BIOGEN INC.: Q2 2024 Earnings Release (Projected) |
| 23/07/2024 07:00 | BIOGAIA AB: Q2 2024 Earnings Release |
| 23/07/2024 | SAMSUNG BIOLOGICS CO.,LTD.: Q2 2024 Earnings Release (Projected) |
| 24/07/2024 | PHARMA MAR, S.A.: Q2 2024 Earnings Release (Projected) |
| 24/07/2024 | GRIFOLS, S.A.: Q2 2024 Earnings Release (Projected) |
| 25/07/2024 06:00 | UCB: Q2 2024 Earnings Release |
| 25/07/2024 | SK BIOSCIENCE CO.,LTD.: Q2 2024 Earnings Release (Projected) |
| 29/07/2024 | BIOMARIN PHARMACEUTICAL INC.: Q2 2024 Earnings Release (Projected) |
Past sector events for Humanigen, Inc.
| 23/05/2024 10:43 | CONCORD BIOTECH LIMITED: Q4 2024 Earnings Release |
| 14/05/2024 16:35 | GRIFOLS, S.A.: Q1 2024 Earnings Release |
| 13/05/2024 | NATURECELL CO.,LTD.: Q1 2024 Earnings Release |
| 12/05/2024 | ALTEOGEN INC.: Q1 2024 Earnings Release (Projected) |
| 09/05/2024 | PHARMARESEARCH CO., LTD.: Q1 2024 Earnings Release |
| 09/05/2024 | MEDY-TOX INC.: Q1 2024 Earnings Release |
| 09/05/2024 21:05 | AVIDITY BIOSCIENCES, INC.: Q1 2024 Earnings Release |
| 09/05/2024 21:05 | ADMA BIOLOGICS, INC.: Q1 2024 Earnings Release |
| 09/05/2024 07:30 | NXERA PHARMA CO., LTD.: Q1 2024 Earnings Release |
| 08/05/2024 | HUGEL, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- HGENQ Stock
- 0KB2 Stock
- Calendar Humanigen, Inc.